Apellis Pharmaceuticals, Inc. (APLS)
21.02
+0.55
(+2.69%)
USD |
NASDAQ |
Jan 21, 11:43
Apellis Pharmaceuticals EPS Diluted (Quarterly): 1.658 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Fortress Biotech, Inc. | 0.111 |
| Sarepta Therapeutics, Inc. | -1.795 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 215.72M |
| Revenue (Quarterly) | 458.58M |
| Total Expenses (Quarterly) | 242.86M |
| Enterprise Value | 2.585B |
| Gross Profit Margin (Quarterly) | 94.58% |
| Profit Margin (Quarterly) | 47.04% |
| Earnings Yield | 1.41% |
| Operating Earnings Yield | 3.02% |
| Normalized Earnings Yield | 1.413 |